US Patent Issued to REGENERON PHARMACEUTICALS on Aug. 23 for "Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)" (New York, Washington Inventors)

Press/Media

Period24 Aug 2022

Media coverage

1

Media coverage

  • TitleUS Patent Issued to REGENERON PHARMACEUTICALS on Aug. 23 for "Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)" (New York, Washington Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date24/08/22
    PersonsAna Kostic
View all 1
View less